EMG-Controlled Prosthetic Ankle for Below Knee Amputation
Trial Summary
What is the purpose of this trial?
The objective of this proposal is to investigate the effects of training to use direct electromyographic (dEMG) control of a powered prosthetic ankle on transtibial amputees'. The aimed questions to answer: 1. whether dEMG control will improve balance and postural stability of amputees, 2. whether dEMG control will lead to more natural neuromuscular control and coordination, 3) whether dEMG control will reduce cognitive processes. Participants will go through PT guided training on using dEMG controlled prosthetic ankles and are evaluated for their capability on functional tasks. The results will be compared with a comparison group, which goes through the same training but with their everyday passive prostheses on balance capability, neuromuscular coordination, and cognitive load during locomotion.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment EMG-Controlled Prosthetic Ankle for Below Knee Amputation?
Research shows that using EMG signals to control a powered prosthetic ankle, combined with physical therapy, can improve balance and stability in people with below-knee amputations. A case study found that this approach led to better postural control and reduced reliance on other joints compared to a passive prosthesis.12345
Is the EMG-controlled prosthetic ankle safe for humans?
The research suggests that using EMG signals to control a powered prosthetic ankle is feasible and can improve balance and postural control in individuals with below-knee amputations. However, the studies primarily focus on feasibility and functionality, and do not provide detailed safety data, indicating a need for further research to confirm safety in a larger group of participants.12346
How does the EMG-controlled prosthetic ankle treatment differ from other treatments for below-knee amputation?
The EMG-controlled prosthetic ankle treatment is unique because it uses electromyographic (EMG) signals from the user's muscles to provide direct and continuous control of the prosthetic ankle, allowing for more natural movement and improved postural control. This approach, combined with physical therapy-guided training, enhances the user's ability to perform daily activities with better balance and less reliance on intact joints, unlike traditional passive prostheses that do not offer such dynamic control.12357
Research Team
He Huang, PhD
Principal Investigator
NC State University
Eligibility Criteria
This trial is for individuals with below-knee amputations. Participants should be able to undergo physical therapy (PT) and use a direct electromyographic (dEMG) controlled prosthetic ankle. Specific inclusion or exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Initial evaluation with both powered and passive prostheses to establish baseline measurements
Training
Participants undergo training to use the powered prosthetic ankle, focusing on muscle coordination and integration with full body motion
Post-training Evaluation
Evaluation of the impact of the training program on participants' performance with both prosthetic types
Follow-up
Participants are monitored for long-term effects of the training program on balance and postural control
Treatment Details
Interventions
- direct EMG controlled prosthetic ankle
- PT guided prosthetic training
direct EMG controlled prosthetic ankle is already approved in United States for the following indications:
- Transtibial amputation rehabilitation
- Balance and postural stability improvement
- Neuromuscular control and coordination enhancement
Find a Clinic Near You
Who Is Running the Clinical Trial?
North Carolina State University
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborator